New Oral Anticoagulants in Patients Undergoing Atrial Flutter Radiofrequency Catheter Ablation: an Observational Study

References

• Gallego AM , Díaz-InfanteE, García-BolaoI . [Spanish Catheter Ablation Registry. 10th official report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2010)] . Rev. Esp. Cardiol.64 ( 12 ), 1147 – 1153 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lanzarotti CJ , OlshanskyB . Thromboembolism in chronic atrial flutter: is the risk underestimated?J. Am. Coll. Cardiol.30 ( 6 ), 1506 – 1511 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Ghali WA , WasilBI, BrantR, ExnerDV, CornuzJ . Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis . Am. J. Med.118 ( 2 ), 101 – 107 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Blomström-Lundqvist C , ScheinmanMM, AliotEMet al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias) . Circulation108 ( 15 ), 1871 – 1909 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Calkins H , KuckKH, CappatoRet al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design . Europace14 ( 4 ), 528 – 606 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Finlay M , SawhneyV, SchillingRet al. Uninterrupted warfarin for periprocedural anticoagulation in catheter ablation of typical atrial flutter: a safe and cost-effective strategy . J. Cardiovasc. Electrophysiol.21 ( 2 ), 150 – 154 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Snipelisky D , KauffmanC, PrussakK, JohnsG, VenkatachalamK, KusumotoF . A comparison of bleeding complications post-ablation between warfarin and dabigatran . J. Interv. Card. Electrophysiol.35 ( 1 ), 29 – 33 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kaiser DW , StreurMM, NagarakantiR, WhalenSP, EllisCR . Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter . J. Interv. Card. Electrophysiol.37 ( 3 ), 241 – 247 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kim JS , SheF, JongnarangsinKet al. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation . Heart Rhythm10 ( 4 ), 483 – 489 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Winkle RA , MeadRH, EngelG, KongMH, PatrawalaRA . The use of dabigatran immediately after atrial fibrillation ablation . J. Cardiovasc. Electrophysiol.23 ( 3 ), 264 – 268 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kaseno K , NaitoS, NakamuraKet al. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation . Circ. J.76 ( 10 ), 2337 – 2342 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lakkireddy D , ReddyYM, Di BiaseLet al. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry . J. Am. Coll. Cardiol.59 ( 13 ), 1168 – 1174 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bassiouny M , SalibaW, RickardJet al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation . Circ. Arrhythm. Electrophysiol.6 ( 3 ), 460 – 466 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nin T , SairakuA, YoshidaYet al. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation . Pacing Clin. Electrophysiol.36 ( 2 ), 172 – 179 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Eitel C , KochJ, SommerPet al. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation . Europace15 ( 11 ), 1587 – 1593 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Imamura K , YoshidaA, TakeiAet al. Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay . J. Interv. Card. Electrophysiol.37 ( 3 ), 223 – 231 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Maddox W , KayGN, YamadaTet al. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation . J. Cardiovasc. Electrophysiol.24 ( 8 ), 861 – 865 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pradaxa (dabigatran etexilate): summary of product characteristics . www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf ( Accessed 16May2014 ).
   Google Scholar
• Piccini JP , StevensSR, LokhnyginaYet al. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial . J. Am. Coll. Cardiol.61 ( 19 ), 1998 – 2006 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hohnloser SH , CammAJ . Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature . Europace15 ( 10 ), 1407 – 1411 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bin Abdulhak AA , KhanAR, TleyjehIMet al. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis . Europace15 ( 10 ), 1412 – 1420 ( 2013 ).
   PubMed Web of Science ®Google Scholar